Low lipoprotein (a) levels during acute viral hepatitis

Area of Science:

• Cardiovascular Medicine
• Hepatology
• Biochemistry

Background:

• High serum lipoprotein (a) [Lp(a)] is a risk factor for atherosclerosis.
• Lp(a) comprises apolipoprotein B-100 and apolipoprotein (a) [apo(a)], with size polymorphism influencing serum levels.
• Lp(a) is synthesized in the liver, prompting investigation into its relationship with liver disease.

Purpose of the Study:

• To investigate the impact of acute viral hepatitis on serum Lp(a) concentrations.
• To compare Lp(a) levels in patients with acute hepatitis versus healthy controls.
• To examine the longitudinal changes in Lp(a) during and after acute hepatitis.

Main Methods:

• Serum Lp(a) concentrations were measured in 74 patients with acute viral hepatitis (A, B, C) and 404 healthy controls.
• A subgroup of 23 patients was monitored longitudinally during and after hepatitis.
• Statistical analyses included Mann-Whitney and Wilcoxon tests; apo(a) isoform distribution was assessed using chi-squared test.

Main Results:

• Median Lp(a) levels were significantly lower in patients with acute hepatitis (7 mg/dL) compared to controls (17 mg/dL) (P < .0001).
• The observed decrease in Lp(a) was independent of apo(a) isoform size and not due to unequal isoform distribution.
• During convalescence, Lp(a) concentrations markedly increased in patients, from 7 to 32 mg/dL (P < .0001).

Conclusions:

• Acute hepatitis is associated with significantly diminished serum Lp(a) levels.
• Serum Lp(a) levels increase during recovery from acute hepatitis.
• Further research is warranted to explore the clinical utility of Lp(a) as a liver function parameter.